These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 10611317)

  • 1. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.
    Ogilvy S; Metcalf D; Print CG; Bath ML; Harris AW; Adams JM
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14943-8. PubMed ID: 10611317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral transduction of enriched hematopoietic stem cells allows lifelong Bcl-2 expression in multiple lineages but does not perturb hematopoiesis.
    Innes KM; Szilvassy SJ; Davidson HE; Gibson L; Adams JM; Cory S
    Exp Hematol; 1999 Jan; 27(1):75-87. PubMed ID: 9923446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment.
    Ogilvy S; Metcalf D; Gibson L; Bath ML; Harris AW; Adams JM
    Blood; 1999 Sep; 94(6):1855-63. PubMed ID: 10477714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.
    Campbell KJ; Bath ML; Turner ML; Vandenberg CJ; Bouillet P; Metcalf D; Scott CL; Cory S
    Blood; 2010 Oct; 116(17):3197-207. PubMed ID: 20631380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells.
    Weber-Nordt RM; Henschler R; Schott E; Wehinger J; Behringer D; Mertelsmann R; Finke J
    Blood; 1996 Oct; 88(7):2549-58. PubMed ID: 8839847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2.
    Lu L; Chaudhury P; Osmond DG
    J Immunol; 1999 Feb; 162(4):1931-40. PubMed ID: 9973461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow and thymus expression of interferon-gamma results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies.
    Young HA; Klinman DM; Reynolds DA; Grzegorzewski KJ; Nii A; Ward JM; Winkler-Pickett RT; Ortaldo JR; Kenny JJ; Komschlies KL
    Blood; 1997 Jan; 89(2):583-95. PubMed ID: 9002962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of Bcl-2 on T and B cells in transgenic mice.
    Katsumata M; Siegel RM; Louie DC; Miyashita T; Tsujimoto Y; Nowell PC; Greene MI; Reed JC
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11376-80. PubMed ID: 1454823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vav promoter-tTA conditional transgene expression system for hematopoietic cells drives high level expression in developing B and T cells.
    Kim WI; Wiesner SM; Largaespada DA
    Exp Hematol; 2007 Aug; 35(8):1231-9. PubMed ID: 17560009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage.
    Zhou P; Qian L; Bieszczad CK; Noelle R; Binder M; Levy NB; Craig RW
    Blood; 1998 Nov; 92(9):3226-39. PubMed ID: 9787159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis.
    Tuzlak S; Haschka MD; Mokina AM; Rülicke T; Cory S; Labi V; Villunger A
    FEBS J; 2018 Apr; 285(8):1403-1418. PubMed ID: 29498802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Flt3 is expressed at the hematopoietic stem cell and the granulocyte/macrophage progenitor stages to maintain cell survival.
    Kikushige Y; Yoshimoto G; Miyamoto T; Iino T; Mori Y; Iwasaki H; Niiro H; Takenaka K; Nagafuji K; Harada M; Ishikawa F; Akashi K
    J Immunol; 2008 Jun; 180(11):7358-67. PubMed ID: 18490735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human granulocyte-macrophage colony-stimulating factor (hGM-CSF)-dependent in vitro and in vivo proliferation and differentiation of all hematopoietic progenitor cells in hGM-CSF receptor transgenic mice.
    Nishijima I; Watanabe S; Nakahata T; Arai K
    J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S79-86. PubMed ID: 9440551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
    Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
    J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC levels govern hematopoietic tumor type and latency in transgenic mice.
    Smith DP; Bath ML; Metcalf D; Harris AW; Cory S
    Blood; 2006 Jul; 108(2):653-61. PubMed ID: 16537801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA.
    Wulf GM; Adra CN; Lim B
    EMBO J; 1993 Dec; 12(13):5065-74. PubMed ID: 8262049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
    Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
    Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation.
    Domen J; Gandy KL; Weissman IL
    Blood; 1998 Apr; 91(7):2272-82. PubMed ID: 9516125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice.
    Grillot DA; Merino R; Núñez G
    J Exp Med; 1995 Dec; 182(6):1973-83. PubMed ID: 7500043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cell production and turnover in CBA/Ca, CBA/N and CBA/N-bcl-2 transgenic mice: xid-mediated failure among pre B cells is unaltered by bcl-2 overexpression.
    Cancro MP; Sah AP; Levy SL; Allman DM; Constantinescu D; Schmidt MR; Woodland RT
    Curr Top Microbiol Immunol; 2000; 252():31-8. PubMed ID: 11125490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.